| New findings in pancreatic and intestinal endocrine development to advance regenerative medicine. | |
| | |
MedLine Citation:
|
PMID: 23249759 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: We highlight some of the major recent advances that have been made towards understanding the mechanisms that control endocrine differentiation and cell identity in the pancreas and intestine. RECENT FINDINGS: Notch signaling plays a complex role in the fate choice between endocrine, duct, and acinar lineages in the developing pancreas. New approaches to dissecting the role of mesenchymal cells in the developing endocrine pancreas reveal inhibitory signals from the endothelium. Epigenetic mechanisms represent another layer of control over pancreatic development and β cell identity. Further details on the transcriptional control of enteroendocrine cell development have emerged and revealed a surprising role for FoxO1 in restraining insulin expression in the gut. Incremental progress is being made in the field of directed differentiation of embryonic stem cells to pancreatic β cells and the first reported differentiation of human embryonic stem cells into intestinal organoids containing enteroendocrine cells represents a major breakthrough. SUMMARY: Greater knowledge of the fundamental processes controlling endocrine development in the pancreas and intestine has the potential to advance the field of regenerative medicine by providing a pathway to successfully create cell types of clinical interest. |
| | |
Authors:
|
Peter J Carolan; Douglas A Melton |
Related Documents
:
|
23267179 - High-throughput gene expression analysis at the level of single proteins using a microf... 23394599 - Multicellular tumor spheroid models to explore cell cycle checkpoints in 3d. 21148109 - Uncovering gene regulatory networks during mouse fetal germ cell development. 23408179 - Mir-155 down regulation by lna inhibitor can reduce cell growth and proliferation in pc... 23311629 - Key structure of brij for overcoming multidrug resistance in cancer. 23404329 - The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in... 16667039 - Genetic transformation of maize cells by particle bombardment. 8988629 - Ginsenosides increase secretion of lipoprotein lipase by 3t3-l1 adipocytes. 12711279 - Relevance of disseminated tumour cells in blood and bone marrow of patients with solid ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current opinion in endocrinology, diabetes, and obesity Volume: 20 ISSN: 1752-2978 ISO Abbreviation: Curr Opin Endocrinol Diabetes Obes Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2012-12-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101308636 Medline TA: Curr Opin Endocrinol Diabetes Obes Country: England |
Other Details:
|
Languages: eng Pagination: 1-7 Citation Subset: IM |
Affiliation:
|
aGastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston bDepartment of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compr...
Next Document: Omega-6 polyunsaturated fatty acids and the early origins of obesity.